Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-24

FDA Approved: ANASTROZOLE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for ANASTROZOLE from Aurobindo Pharma Limited, authorizing a new generic version of the aromatase inhibitor used in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)

Snippet

SUPPL AP for ANASTROZOLE (ANASTROZOLE)